1. ScholarBank@NUS

Wan-Teck Darren Lim

rp07954

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Wan-Teck Darren Lim
Variants
Lim, W.-T.
 
Main Affiliation
 
Faculty
 
Email
gmslwtd@nus.edu.sg
 

Publications

Refined By:
Department:  DUKE-NUS MEDICAL SCHOOL
Subject:  Life Sciences & Biomedicine

Results 1-20 of 26 (Search time: 0.009 seconds).

Issue DateTitleAuthor(s)
1Nov-2023A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaRazak, Albiruni R Abdul; Wang, Hung-Ming; Chang, Jang-Yang; Ahn, Myung-Ju; Munster, Pamela; Blumenschein Jr, George; Solomon, Benjamin; Lim, Darren Wan-Teck ; Hong, Ruey-Long; Pfister, David; Saba, Nabil F; Lee, Se-Hoon; van Herpen, Carla; Quadt, Cornelia; Bootle, Douglas; Blumenstein, Lars; Demanse, David; Delord, Jean-Pierre
2Dec-2022A Randomized Phase 2 Trial of Nivolumab Versus Nivolumab-Ipilimumab Combination in EGFR-Mutant NSCLCLai, Gillianne GY ; Yeo, Jia Chi; Jain, Amit ; Zhou, Siqin ; Pang, Mengyuan; Alvarez, Jacob JS; Sim, Ngak Leng; Tan, Aaron C ; Suteja, Lisda; Lim, Tze Wei; Guo, Yu Amanda; Shen, Meixin; Saw, Stephanie PL ; Rohatgi, Neha; Yeong, Joe PS; Takano, Angela ; Lim, Kiat Hon ; Gogna, Apoorva ; Too, Chow Wei ; Da Zhuang, Kun ; Tan, Wan Ling ; Kanesvaran, Ravindran ; Ng, Quan Sing ; Ang, Mei Kim ; Rajasekaran, Tanujaa ; Wang, Lanying; Toh, Chee Keong ; Lim, Wan-Teck ; Tam, Wai Leong ; Tan, Sze Huey ; Skanderup, Anders MJ ; Tan, Eng-Huat ; Tan, Daniel SW 
31-Sep-2020An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid CancerBible, Keith C; Menefee, Michael E; Lin, Chia-Chi Josh; Millward, Michael J; Maples, William J; Goh, Boon Cher ; Karlin, Nina J; Kane, Madeleine A; Adkins, Douglas R; Molina, Julian R; Donehower, Ross C; Lim, Wan-Teck ; Flynn, Patrick J; Richardson, Ronald L; Traynor, Anne M; Rubin, Joseph; LoRusso, Patricia M; Smallridge, Robert C; Burton, Jill K; Suman, Vera J; Kumar, Aditi; Voss, Jessie S; Rumilla, Kandalaria M; Kipp, Benjamin R; Chintakuntlawar, Ashish; Harris, Pamela; Erlichman, Charles
427-Sep-2021Analysis of T cell receptor clonotypes in tumor microenvironment identifies shared cancer-type-specific signaturesTeng, Yvonne HF ; Quah, Hong Sheng ; Suteja, Lisda; Dias, Joao ML; Mupo, Annalisa; Bashford-Rogers, Rachael JM; Vassiliou, George S; Chua, Melvin LK; Tan, Daniel SW ; Lim, Darren WT ; Iyer, N Gopalakrishna 
510-May-2018Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)Ma, Brigette BY; Lim, Wan-Teck ; Goh, Boon-Cher ; Hui, Edwin P; Lo, Kwok-Wai; Pettinger, Adam; Foster, Nathan R; Riess, Jonathan W; Agulnik, Mark; Chang, Alex YC; Chopra, Akhil; Kish, Julie A; Chung, Christine H; Adkins, Douglas R; Cullen, Kevin J; Gitlitz, Barbara J; Lim, Dean W; To, Ka-Fai; Chan, KC Allen; Lo, YM Dennis; King, Ann D; Erlichman, Charles; Yin, Jun; Costello, Brian A; Chan, Anthony TC
6May-2021Complete disease remission in a <i>TP53</i> and <i>KRAS</i> co-mutated brain oligometastatic lung cancer patient after immuno-chemotherapy and surgical resection: a case reportZhu, Shuai; Zhao, Shikang; Zhang, Qian; Li, Shuo; Ren, Dian; Ren, Fan; Zu, Lingling; Wang, Yanye; Lei, Xi; Zhou, Ning; Shi, Tao; Xu, Dongbo; Chen, Gang; Lim, Wan-Teck ; Giusti, Raffaele; Wu, Abraham J; Xu, Song
7Sep-2022Comprehensive analysis of T cell receptor repertoire in patients with<i> KRAS</i> mutant non-small cell lung cancerWang, Yadong; Peng, Ling; Zhao, Ming; Xiong, Yuanyuan; Xue, Jianchao; Li, Bowen; Huang, Zhicheng; Liu, Xinyu ; Yang, Xiaoying; Song, Yang; Bing, Zhongxing; Guo, Chao; Tian, Zhenhuan; Gao, Chao; Cao, Lei ; Cao, Zhili; Li, Ji; Jiang, Xu; Si, Xiaoyan; Zhang, Li; Li, Xiaoguang; Zheng, Zhibo; Song, Mengmeng; Chen, Rongrong; Lim, Wan-Teck ; Pavan, Alberto; Romero, Atocha; Liang, Naixin; Yang, Huaxia; Li, Shanqing
826-Apr-2016Concordance of anaplastic lymphoma kinase (ALK) gene rearrangements between circulating tumor cells and tumor in non-small cell lung cancerTan, Chye Ling ; Lim, Tse Hui ; Lim, Tony KH; Tan, Daniel Shao-Weng ; Chua, Yong Wei; Ang, Mei Kim ; Pang, Brendan ; Lim, Chwee Teck ; Takano, Angela ; Lim, Alvin Soon-Tiong ; Leong, Man Chun; Lim, Wan-Teck 
92-Dec-2022Dietary factors and the risk of lung cancer by epidermal growth factor receptor mutation status and histological subtypesYin, Xin; Lai, Gillianne Geet Yi ; Seow, Adeline; Tan, Daniel Shao Weng ; Lim, Darren Wan-Teck ; Seow, Wei Jie 
10Jun-2023Diverse Resistant Mechanisms Identified Using Serial Next-Generation Sequencing in a Patient With ALK-Rearranged Metastatic Lung Adenocarcinoma: A Case ReportSaw, Stephanie Pei Li ; Lim, Darren Wan-Teck 
1110-Jan-2017Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion StudyNogova, Lucia; Sequist, Lecia V; Garcia, Jose Manuel Perez; Andre, Fabrice; Delord, Jean-Pierre; Hidalgo, Manuel; Schellens, Jan HM; Cassier, Philippe A; Camidge, D Ross; Schuler, Martin; Vaishampayan, Ulka; Burris, Howard; Tian, G Gary; Campone, Mario; Wainberg, Zev A; Lim, Wan-Teck ; LoRusso, Patricia; Shapiro, Geoffrey I; Parker, Katie; Chen, Xueying; Choudhury, Somesh; Ringeisen, Francois; Graus-Porta, Diana; Porter, Dale; Isaacs, Randi; Buettner, Reinhard; Wolf, Juergen
1230-Mar-2021Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutationsChang, Gee-Chen; Lam, David Chi-Leung; Tsai, Chun-Ming; Chen, Yuh-Min; Shih, Jin-Yuan; Aggarwal, Shyam; Wang, Shuhang; Kim, Sang-We; Kim, Young-Chul; Wahid, Ibrahim; Li, Rubi; Lim, Darren Wan-Teck ; Sriuranpong, Virote; Chan, Raymond Tsz-Tong; Lorence, Robert M; Carriere, Philippe; Raabe, Christina; Cseh, Agnieszka; Park, Keunchil
13May-2021Individualized Molecular Profiling for Allocation to Clinical Trials Singapore Study-An Asian Tertiary Cancer Center ExperienceSeet, Amanda OL; Tan, Aaron C ; Tan, Tira J ; Ng, Matthew CH; Tai, David WM ; Lam, Justina YC ; San Tan, Gek ; Gogna, Apoorva ; Too, Chow Wei ; Tan, Bien Soo ; Takano, Angela ; Lim, Alvin ; Lim, Tse Hui ; Lim, Soon Thye ; Dent, Rebecca Alexandra ; Ang, Mei Kim ; Yap, Yoon-Sim ; Tan, Iain BH; Choo, Su Pin ; Toh, Chee Keong ; Lim, Elaine H ; Farid, Mohamad; Skanderup, Anders Jacobsen ; Iyer, N Gopalakrishna ; Lim, Wan Teck ; Tan, Eng Huat ; Lim, Tony KH; Tan, Daniel SW 
143-Dec-2018Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastasesTan, Wan-Ling ; Ng, Quan Sing ; Lim, Cindy; Tan, Eng Huat ; Toh, Chee Keong; Ang, Mei-Kim ; Kanesvaran, Ravindran ; Jain, Amit ; Tan, Daniel SW ; Lim, Darren Wan-Teck 
1524-Dec-2018Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases (vol 18, 1198, 2018)Tan, Wan-Ling ; Ng, Quan Sing ; Lim, Cindy; Tan, Eng Huat ; Toh, Chee Keong; Ang, Mei-Kim ; Kanesvaran, Ravindran ; Jain, Amit ; Tan, Daniel SW ; Lim, Darren Wan-Teck 
161-Nov-2021Integrative Profiling of T790M-Negative EGFR-Mutated NSCLC Reveals Pervasive Lineage Transition and Therapeutic OpportunitiesChua, Khi Pin; Teng, Yvonne HF ; Tan, Aaron C ; Takano, Angela ; Alvarez, Jacob JS; Nahar, Rahul; Rohatgi, Neha; Lai, Gillianne GY ; Aung, Zaw Win; Yeong, Joe PS; Lim, Kiat Hon ; Naeini, Marjan Mojtabavi; Kassam, Irfahan ; Jain, Amit ; Tan, Wan Ling ; Gogna, Apoorva ; Too, Chow Wei ; Kanesvaran, Ravindran ; Ng, Quan Sing ; Ang, Mei Kim ; Rajasekaran, Tanujaa ; Anantham, Devanand ; Phua, Ghee Chee ; Tan, Bien Soo ; Lee, Yin Yeng; Wang, Lanying; Teo, Audrey SM; Khng, Alexis Jiaying; Lim, Ming Jie ; Suteja, Lisda; Toh, Chee Keong ; Lim, Wan-Teck ; Iyer, N Gopalakrishna ; Tam, Wai Leong ; Tan, Eng-Huat ; Zhai, Weiwei; Hillmer, Axel M; Skanderup, Anders J ; Tan, Daniel SW 
1717-Jul-2023Landscape of germline pathogenic variants in patients with dual primary breast and lung cancerLee, Ning-Yuan; Hum, Melissa ; Zihara, Sabna; Wang, Lanying; Myint, Matthew K ; Lim, Darren Wan-Teck ; Toh, Chee-Keong ; Skanderup, Anders ; Samol, Jens; Tan, Min-Han ; Ang, Peter; Lee, Soo-Chin ; Tan, Eng-Huat ; Lai, Gillianne GY ; Tan, Daniel SW ; Yap, Yoon-Sim ; Lee, Ann SG 
18Jun-2020Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trialSchuler, M; Berardi, R; Lim, W-T ; de Jonge, M; Bauer, TM; Azaro, A; Gottfried, M; Han, J-Y; Lee, DH; Wollner, M; Hong, DS; Vogel, A; Delmonte, A; Akimov, M; Ghebremariam, S; Cui, X; Nwana, N; Giovannini, M; Kim, TM
1922-May-2019Pan-cancer analysis connects tumor matrisome to immune responseLim, Su Bin; Chua, Melvin Lee Kiang ; Yeong, Joe Poh Sheng; Jin, Swee Jin; Lim, Wan-Teck ; Lim, Chwee Teck 
2030-Dec-2019Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohortsBang, Yung-Jue; Su, Wu-Chou; Schuler, Martin; Nam, Do-Hyun; Lim, Wan Teck ; Bauer, Todd M; Azaro, Analia; Poon, Ronnie Tung Ping; Hong, David; Lin, Chia-Chi; Akimov, Mikhail; Ghebremariam, Samson; Zhao, Sylvia; Giovannini, Monica; Ma, Brigette